-
experiments using state-of-the-art methods. The position is for six months but can be extended by six more months pending the completion of the project. Your profile The person appointed should have a master’s
-
these human cells to immunocompromised mice. There will be possibilities to follow-up key findings with wet lab experiments using state-of-the-art methods. The position is for six months but can be extended by
-
the research process and increase the synergetic effects. As part of KIRI, you will also have the opportunity to meet other KIRI postdocs conducting state-of-the-art research, present your work at scientific
-
assistants, the successful candidate will be responsible for setting up experiments, analyzing data and writing scientific articles. The research group have access to two state-of-the-art 3-Tesla MRI scanners
-
they are formed. To achieve this, we will employ several state-of-the-art approaches including lineage tracing in transplantation models and advanced cell biology work based on human cells. Your profile To be
-
state-of-the-art immune proteogenomic technologies for the visualization of thel host-microbiome interactions at the single cell resolution. The Villablanca lab is part of the Department of Medicine
-
to Biotech companies in order to test experimental molecules and assess their effect on animal models of PsV and PsA. Lastly, single cell RNA sequencing and state-of-the-art proteomic analyses will be applied
-
Research Infrastructure? No Offer Description Do you want to contribute to better health for all? The Meletis Lab is part of an outstanding scientific environment with state-of-the-art infrastructure and
-
the fellows the opportunity to develop and/or apply state-of-the-art imaging methodologies to solve biological mysteries. Necessary training on the advanced bioimaging technologies will be given to the fellows
-
position within a Research Infrastructure? No Offer Description Do you want to contribute to top quality medical research? In the Brodin lab, the team performs state-of-the-art immunomonitoring analyses